Amrize Ltd
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $11.8B | $11.7B | $11.7B | — |
| Cost of revenue | $8.8B | $8.6B | $8.9B | — |
| Gross profit | $3.0B | $3.1B | $2.8B | — |
| Selling, general & administrative | $1.1B | $944.0M | $898.0M | — |
| Operating income | $1.9B | $2.2B | $1.9B | — |
| Interest expense | $461.0M | $547.0M | $564.0M | — |
| Pretax income | $1.5B | $1.6B | $1.3B | — |
| Income tax expense | $326.0M | $368.0M | $361.0M | — |
| Net income | $1.2B | $1.3B | $956.0M | — |
| Balance Sheet | ||||
| Cash and equivalents | $1.9B | $1.6B | — | — |
| Current assets | $4.7B | $4.8B | — | — |
| Total assets | $24.2B | $23.8B | — | — |
| Current liabilities | $2.9B | $2.5B | — | — |
| Total liabilities | $11.0B | $13.9B | — | — |
| Total debt | $5.3B | — | — | — |
| Stockholders' equity | $13.3B | $9.9B | $9.2B | $8.2B |
| Cash Flow Statement | ||||
| Cash from operations | $2.2B | $2.3B | $2.0B | — |
| Depreciation and amortization | $758.0M | $736.0M | $689.0M | — |
| Stock-based compensation | $14.0M | $6.0M | $5.0M | — |
| Capital expenditure | $788.0M | $642.0M | $630.0M | — |
| Free cash flow | $1.4B | $1.6B | $1.4B | — |
| Impairments | $15.0M | $2.0M | $15.0M | — |
Shares outstanding 553.5M · Free float 99.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.